Literature DB >> 23452836

Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients.

Wael Abo El-Kheir1, Hala Gabr, Mohamed Reda Awad, Osama Ghannam, Yousef Barakat, Haithem A M A Farghali, Zeinab M El Maadawi, Ibrahim Ewes, Hatem E Sabaawy.   

Abstract

Spinal cord injuries (SCI) cause sensory loss and motor paralysis. They are normally treated with physical therapy, but most patients fail to recover due to limited neural regeneration. Here we describe a strategy in which treatment with autologous adherent bone marrow cells is combined with physical therapy to improve motor and sensory functions in early stage chronic SCI patients. In a phase I/II controlled single-blind clinical trial (clinicaltrials.gov identifier: NCT00816803), 70 chronic cervical and thoracic SCI patients with injury durations of at least 12 months were treated with either intrathecal injection(s) of autologous adherent bone marrow cells combined with physical therapy or with physical therapy alone. Patients were evaluated with clinical and neurological examinations using the American Spinal Injury Association (ASIA) Impairment Scale (AIS), electrophysiological somatosensory-evoked potential, magnetic resonance imaging (MRI), and functional independence measurements. Chronic cervical and thoracic SCI patients (15 AIS A and 35 AIS B) treated with autologous adherent bone marrow cells combined with physical therapy showed functional improvements over patients in the control group (10 AIS A and 10 AIS B) treated with physical therapy alone, and there were no long-term cell therapy-related side effects. At 18 months posttreatment, 23 of the 50 cell therapy-treated cases (46%) showed sustained functional improvement. Compared to those patients with cervical injuries, a higher rate of functional improvement was achieved in thoracic SCI patients with shorter durations of injury and smaller cord lesions. Therefore, when combined with physical therapy, autologous adherent bone marrow cell therapy appears to be a safe and promising therapy for patients with chronic SCI of traumatic origin. Randomized controlled multicenter trials are warranted.

Entities:  

Mesh:

Year:  2013        PMID: 23452836     DOI: 10.3727/096368913X664540

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  41 in total

1.  Electrophysiological Outcome Measures in Spinal Cord Injury Clinical Trials: A Systematic Review.

Authors:  Radha Korupolu; Argyrios Stampas; Mani Singh; Ping Zhou; Gerard Francisco
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

Review 2.  Effects of mesenchymal stem cell transplantation on spinal cord injury patients.

Authors:  Fatemeh Tahmasebi; Shirin Barati
Journal:  Cell Tissue Res       Date:  2022-06-14       Impact factor: 4.051

Review 3.  Stem cell-based therapy for human diseases.

Authors:  Duc M Hoang; Phuong T Pham; Trung Q Bach; Anh T L Ngo; Quyen T Nguyen; Trang T K Phan; Giang H Nguyen; Phuong T T Le; Van T Hoang; Nicholas R Forsyth; Michael Heke; Liem Thanh Nguyen
Journal:  Signal Transduct Target Ther       Date:  2022-08-06

Review 4.  Mesenchymal Stromal Cell Therapy in Spinal Cord Injury: Mechanisms and Prospects.

Authors:  Ji-Le Xie; Xing-Ran Wang; Mei-Mei Li; Zi-Han Tao; Wen-Wen Teng
Journal:  Front Cell Neurosci       Date:  2022-06-03       Impact factor: 6.147

Review 5.  Clinical application of stem cell therapy in neurogenic bladder: a systematic review and meta-analysis.

Authors:  Hanieh Salehi-Pourmehr; Ozra Nouri; Amirreza Naseri; Leila Roshangar; Reza Rahbarghazi; Saeed Sadigh-Eteghad; Javad Mahmoudi; Hadi Mostafaei; M Reza Roshandel; Leila Hoseini; Nasrin Abolhasanpour; Ali Mostafaei; Sakineh Hajebrahimi; Hashim Hashim
Journal:  Int Urogynecol J       Date:  2021-11-12       Impact factor: 1.932

6.  Engrafted peripheral blood-derived mesenchymal stem cells promote locomotive recovery in adult rats after spinal cord injury.

Authors:  Qiang Fu; Yi Liu; Xiu Liu; Qian Zhang; Long Chen; Jiachen Peng; Jun Ao; Yuwan Li; Shengmin Wang; Gongyu Song; Limei Yu; Jinwei Liu; Tao Zhang
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

7.  Intrathecal Transplantation of Autologous Adherent Bone Marrow Cells Induces Functional Neurological Recovery in a Canine Model of Spinal Cord Injury.

Authors:  Hala Gabr; Wael Abo El-Kheir; Haithem A M A Farghali; Zeinab M K Ismail; Maha B Zickri; Zeinab M El Maadawi; Nirmeen A Kishk; Hatem E Sabaawy
Journal:  Cell Transplant       Date:  2014-07-15       Impact factor: 4.064

Review 8.  Is cell transplantation a reliable therapeutic strategy for spinal cord injury in clinical practice? A systematic review and meta-analysis from 22 clinical controlled trials.

Authors:  He Zhao; Qing-Ling Sun; Li-Jun Duan; Yong-Dong Yang; Yu-Shan Gao; Ding-Yan Zhao; Yang Xiong; He-Jun Wang; Jia-Wei Song; Kai-Tan Yang; Xiu-Mei Wang; Xing Yu
Journal:  Eur Spine J       Date:  2019-01-21       Impact factor: 3.134

Review 9.  Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells.

Authors:  Nazmul Haque; Noor Hayaty Abu Kasim; Mohammad Tariqur Rahman
Journal:  Int J Biol Sci       Date:  2015-02-05       Impact factor: 6.580

10.  Minimally manipulated autologous adherent bone marrow cells (ABMCs): a promising cell therapy of spinal cord injury.

Authors:  Kamana Misra; Hatem E Sabaawy
Journal:  Neural Regen Res       Date:  2015-07       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.